In last trading session, RAPT Therapeutics Inc (NASDAQ:RAPT) saw 0.84 million shares changing hands with its beta currently measuring 0.47. Company’s recent per share price level of $9.38 trading at $0.36 or 3.99% at ring of the bell on the day assigns it a market valuation of $326.42M. That closing price of RAPT’s stock is at a discount of -191.58% from its 52-week high price of $27.35 and is indicating a premium of 26.87% from its 52-week low price of $6.86. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.82 million shares which gives us an average trading volume of 1.31 million if we extend that period to 3-months.
RAPT Therapeutics Inc (NASDAQ:RAPT) trade information
Upright in the green during last session for gaining 3.99%, in the last five days RAPT remained trading in the green while hitting it’s week-highest on Thursday, 04/11/24 when the stock touched $9.38 price level, adding 2.8% to its value on the day. RAPT Therapeutics Inc’s shares saw a change of -62.25% in year-to-date performance and have moved 17.10% in past 5-day. RAPT Therapeutics Inc (NASDAQ:RAPT) showed a performance of 17.69% in past 30-days. Number of shares sold short was 3.3 million shares which calculate 1.21 days to cover the short interests.
RAPT Therapeutics Inc (RAPT) estimates and forecasts
Statistics highlight that RAPT Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -36.28% of value to its shares in past 6 months, showing an annual growth rate of -4.59% while that of industry is 13.60. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to decrease by -6.60% in the current quarter and calculating -25.80% decrease in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -12.39% during past 5 years.
RAPT Dividends
RAPT Therapeutics Inc is more likely to be releasing its next quarterly report in May and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
RAPT Therapeutics Inc (NASDAQ:RAPT)’s Major holders
Insiders are in possession of 1.81% of company’s total shares while institution are holding 102.66 percent of that, with stock having share float percentage of 104.55%. Investors also watch the number of corporate investors in a company very closely, which is 102.66% institutions for RAPT Therapeutics Inc that are currently holding shares of the company. FMR, LLC is the top institutional holder at RAPT for having 4.19 million shares of worth $78.36 million. And as of Jun 29, 2023, it was holding 12.20% of the company’s outstanding shares.
The second largest institutional holder is Price (T.Rowe) Associates Inc, which was holding about 3.49 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 10.15% of outstanding shares, having a total worth of $65.22 million.
On the other hand, Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 2.02 million shares of worth $37.81 million or 5.88% of the total outstanding shares. The later fund manager was in possession of 1.2 million shares on Jun 29, 2023, making its stake of worth around $22.46 million in the company or a holder of 3.50% of company’s stock.
